The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate
sodium sulfate, potassium sulfate, magnesium sulfate · SODIUM SULFATE 13.13 g/133.1mL; POTASSIUM SULFATE 2.35 g/133.1mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 1.2 g/133.1mL · Solution, Concentrate · Oral · Wilshire Pharmaceuticals, Inc.
NDC 52536-0177-01 · 2 BOTTLE, PLASTIC in 1 CARTON / 133.1 mL in 1 BOTTLE, PLASTIC · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for sodium sulfate, potassium sulfate, magnesium sulfate (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA022372
- TE code
- AA
- Approval date
- Aug 5, 2010
- Patents / exclusivity
- 0 patents, 1 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | ODE-315 | Aug 5, 2027 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of sodium sulfate, potassium sulfate, magnesium sulfate (Solution, Concentrate)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Affordable Pharmaceuticals, LLC | SODIUM SULFATE 17.5 g/mL; POTASSIUM SULFATE 3.13 g/mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 1.6 g/mL | Aug 26, 2026 | Sep 2, 2026 |
| Affordable Pharmaceuticals, LLC | SODIUM SULFATE 13.13 g/133.1mL; POTASSIUM SULFATE 2.35 g/133.1mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 1.2 g/133.1mL | Aug 26, 2026 | Sep 2, 2026 |
| Azurity Pharmaceuticals, Inc. | SODIUM SULFATE 13.13 g/133.1mL; POTASSIUM SULFATE 2.35 g/133.1mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 1.2 g/133.1mL | Aug 26, 2026 | Sep 2, 2026 |
| Azurity Pharmaceuticals, Inc. | SODIUM SULFATE 17.5 g/mL; POTASSIUM SULFATE 3.13 g/mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 1.6 g/mL | Aug 26, 2026 | Sep 2, 2026 |
| Braintree Laboratories, Inc. | SODIUM SULFATE 17.5 g/mL; POTASSIUM SULFATE 3.13 g/mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 1.6 g/mL | Aug 26, 2026 | Sep 2, 2026 |
| Braintree Laboratories, Inc. | SODIUM SULFATE 13.13 g/133.1mL; POTASSIUM SULFATE 2.35 g/133.1mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 1.2 g/133.1mL | Aug 26, 2026 | Sep 2, 2026 |
| Wilshire Pharmaceuticals, Inc. | SODIUM SULFATE 13.13 g/133.1mL; POTASSIUM SULFATE 2.35 g/133.1mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 1.2 g/133.1mL | Aug 26, 2026 | Sep 2, 2026 |
| Wilshire Pharmaceuticals, Inc. | SODIUM SULFATE 17.5 g/mL; POTASSIUM SULFATE 3.13 g/mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 1.6 g/mL | Aug 26, 2026 | Sep 2, 2026 |
| Affordable Pharmaceuticals, LLC | SODIUM SULFATE 1.6 g/mL; POTASSIUM SULFATE 3.13 g/mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 17.5 g/mL | Jul 22, 2026 | Aug 19, 2026 |
| Affordable Pharmaceuticals, LLC | SODIUM SULFATE 1.2 g/133.1mL; POTASSIUM SULFATE 2.35 g/133.1mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 13.13 g/133.1mL | Jul 22, 2026 | Aug 19, 2026 |
| Azurity Pharmaceuticals, Inc. | SODIUM SULFATE 1.6 g/mL; POTASSIUM SULFATE 3.13 g/mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 17.5 g/mL | Jul 22, 2026 | Aug 19, 2026 |
| Azurity Pharmaceuticals, Inc. | SODIUM SULFATE 1.2 g/133.1mL; POTASSIUM SULFATE 2.35 g/133.1mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 13.13 g/133.1mL | Jul 22, 2026 | Aug 19, 2026 |
| Braintree Laboratories, Inc. | SODIUM SULFATE 1.2 g/133.1mL; POTASSIUM SULFATE 2.35 g/133.1mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 13.13 g/133.1mL | Jul 22, 2026 | Aug 19, 2026 |
| Braintree Laboratories, Inc. | SODIUM SULFATE 1.6 g/mL; POTASSIUM SULFATE 3.13 g/mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 17.5 g/mL | Jul 22, 2026 | Aug 19, 2026 |
| Wilshire Pharmaceuticals, Inc. | SODIUM SULFATE 1.6 g/mL; POTASSIUM SULFATE 3.13 g/mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 17.5 g/mL | Jul 22, 2026 | Aug 19, 2026 |
| Wilshire Pharmaceuticals, Inc. | SODIUM SULFATE 1.2 g/133.1mL; POTASSIUM SULFATE 2.35 g/133.1mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 13.13 g/133.1mL | Jul 22, 2026 | Aug 19, 2026 |
| Affordable Pharmaceuticals, LLC | MAGNESIUM SULFATE, UNSPECIFIED FORM 1.6 g/mL; POTASSIUM SULFATE 3.13 g/mL; SODIUM SULFATE 17.5 g/mL | Jul 15, 2026 | Jul 15, 2026 |
| Affordable Pharmaceuticals, LLC | MAGNESIUM SULFATE, UNSPECIFIED FORM 1.2 g/133.1mL; POTASSIUM SULFATE 2.35 g/133.1mL; SODIUM SULFATE 13.13 g/133.1mL | Jul 15, 2026 | Jul 15, 2026 |
| Azurity Pharmaceuticals, Inc. | MAGNESIUM SULFATE, UNSPECIFIED FORM 1.2 g/133.1mL; POTASSIUM SULFATE 2.35 g/133.1mL; SODIUM SULFATE 13.13 g/133.1mL | Jul 15, 2026 | Jul 15, 2026 |
| Azurity Pharmaceuticals, Inc. | MAGNESIUM SULFATE, UNSPECIFIED FORM 1.6 g/mL; POTASSIUM SULFATE 3.13 g/mL; SODIUM SULFATE 17.5 g/mL | Jul 15, 2026 | Jul 15, 2026 |
| Braintree Laboratories, Inc. | MAGNESIUM SULFATE, UNSPECIFIED FORM 1.6 g/mL; POTASSIUM SULFATE 3.13 g/mL; SODIUM SULFATE 17.5 g/mL | Jul 15, 2026 | Jul 15, 2026 |
| Braintree Laboratories, Inc. | MAGNESIUM SULFATE, UNSPECIFIED FORM 1.2 g/133.1mL; POTASSIUM SULFATE 2.35 g/133.1mL; SODIUM SULFATE 13.13 g/133.1mL | Jul 15, 2026 | Jul 15, 2026 |
| Wilshire Pharmaceuticals, Inc. | MAGNESIUM SULFATE, UNSPECIFIED FORM 1.2 g/133.1mL; POTASSIUM SULFATE 2.35 g/133.1mL; SODIUM SULFATE 13.13 g/133.1mL | Jul 15, 2026 | Jul 15, 2026 |
| Wilshire Pharmaceuticals, Inc. | MAGNESIUM SULFATE, UNSPECIFIED FORM 1.6 g/mL; POTASSIUM SULFATE 3.13 g/mL; SODIUM SULFATE 17.5 g/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate — NDC 52536-0177-01," retrieved September 3, 2026, https://drugdashboards.com/drug/52536017701.
Free to cite with attribution — see how the data is put together.